4.6 Review

Adipokines in gestational diabetes

Journal

LANCET DIABETES & ENDOCRINOLOGY
Volume 2, Issue 6, Pages 488-499

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S2213-8587(13)70176-1

Keywords

-

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [SFB 1052/1, C06]
  2. Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001, K7-9]
  3. Deutsche Hochdruckliga e.V.
  4. ICEMED alliance (Helmholtz Gemeinschaft)

Ask authors/readers for more resources

Gestational diabetes is characterised by glucose intolerance with onset or first recognition during pregnancy. The disease shows facets of the metabolic syndrome including obesity, insulin resistance, and dyslipidaemia. Adipokines are a group of proteins secreted from adipocytes, which are dysregulated in obesity and contribute to metabolic and vascular complications. Recent studies have assessed the role of various adipokines including leptin, adiponectin, tumour necrosis factor alpha (TNF alpha), adipocyte fatty acid-binding protein (AFABP), retinol-binding protein 4 (RBP4), resistin, NAMPT, SERPINA12, chemerin, progranulin, FGF-21, TIMP1, LCN2, AZGP1, apelin (APLN), and omentin in gestational diabetes. This Review provides an overview of these key adipokines, their regulation in, and potential contribution to gestational diabetes. Based on the evidence so far, the adipokines adiponectin, leptin, TNF alpha, and AFABP seem to be the most probable candidates involved in the pathophysiology of gestational diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available